Table 3.
Groups | Absolute Organ Weight (g) | |||
---|---|---|---|---|
Liver | Kidney | Periovarian Fats | Pancreas | |
Controls | ||||
Intact | 0.896 ± 0.020 | 0.114 ± 0.006 | 0.042 ± 0.019 | 0.103 ± 0.011 |
db | 2.552 ± 0.121 f | 0.233 ± 0.017 f | 0.772 ± 0.097 a | 0.141 ± 0.017 a |
Reference | ||||
Metformin | 2.084 ± 0.118 fg | 0.207 ± 0.011 fg | 0.560 ± 0.082 ac | 0.131 ± 0.011 a |
GT 400 mg/kg | 2.062 ± 0.107 fg | 0.208 ± 0.010 fg | 0.567 ± 0.102 ac | 0.135 ± 0.021 a |
fGT treated | ||||
400 mg/kg | 1.366 ± 0.352 fgh | 0.180 ± 0.005 fgh | 0.350 ± 0.067 ace | 0.123 ± 0.020 bd |
200 mg/kg | 1.546 ± 0.257 fgh | 0.189 ± 0.014 fgh | 0.380 ± 0.058 ace | 0.127 ± 0.017 a |
100 mg/kg | 1.949 ± 0.167 fg | 0.200 ± 0.016 fg | 0.486 ± 0.119 ac | 0.126 ± 0.018 a |
Values are expressed as mean ± S.D. of eight mice. GT, Green tea aqueous lyophilized extracts; fGT, Aquilariae Lignum-fermented green tea aqueous lyophilized extracts; metformin was administrated at a dose level of 250 mg/kg; a p < 0.01 and b p < 0.05 as compared with intact control by LSD test; c p < 0.01 and d p < 0.05 as compared with db control by LSD test; e p < 0.01 as compared with GT 400 mg/kg by LSD test; f p < 0.01 as compared with intact control by MW test; g p < 0.01 as compared with db control by MW test; h p < 0.01 as compared with GT 400 mg/kg by MW test.